Advanced Biomed (NASDAQ:ADVB) Announces Quarterly Earnings Results

Advanced Biomed (NASDAQ:ADVB) posted its earnings results on Friday. The company reported ($0.38) earnings per share for the quarter, Zacks reports.

Advanced Biomed Stock Performance

Shares of NASDAQ:ADVB traded down $0.03 during midday trading on Friday, reaching $4.40. 13,558 shares of the company were exchanged, compared to its average volume of 391,197. Advanced Biomed has a fifty-two week low of $3.61 and a fifty-two week high of $25.60. The stock’s fifty day moving average price is $5.20. The firm has a market cap of $5.98 million, a price-to-earnings ratio of 1.16 and a beta of 0.56.

Wall Street Analyst Weigh In

Separately, Weiss Ratings initiated coverage on shares of Advanced Biomed in a report on Monday, January 26th. They set a “sell (e+)” rating on the stock. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.

About Advanced Biomed

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.